Cargando…

The impact of chronic obstructive pulmonary disease on intensive care unit admission and 30-day mortality in patients undergoing colorectal cancer surgery: a Danish population-based cohort study

BACKGROUND AND PURPOSE: Chronic obstructive pulmonary disease (COPD) may increase the risk of postoperative complications and thus mortality after colorectal cancer (CRC) surgery, but the evidence is sparse. METHODS: We conducted this nationwide population-based cohort study in Denmark, including al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Platon, Anna Maria, Erichsen, Rune, Christiansen, Christian Fynbo, Andersen, Lea Kjær, Sværke, Claus, Montomoli, Jonathan, Sørensen, Henrik Toft
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212724/ https://www.ncbi.nlm.nih.gov/pubmed/25478184 http://dx.doi.org/10.1136/bmjresp-2014-000036

Ejemplares similares

Comorbidities and mortality among patients with chronic obstructive pulmonary disease
por: Skajaa, Nils, et al.
Publicado: (2023)

Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
por: Wang, Ye, et al.
Publicado: (2023)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

Interventions to standardise hospital care at presentation, admission or discharge or to reduce unnecessary admissions or readmissions for patients with acute exacerbation of chronic obstructive pulmonary disease: a scoping review
por: MacDonell, Rachel, et al.
Publicado: (2020)

Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
por: Stone, Philip W, et al.
Publicado: (2022)

Time to NIV and mortality in AECOPD hospital admissions: an observational study into real world insights from National COPD Audits
por: Jayadev, Anita, et al.
Publicado: (2019)

Using and implementing care bundles for patients with acute admission for COPD: qualitative study of healthcare professionals’ experience in four hospitals in England
por: Shaw, Ali, et al.
Publicado: (2020)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial
por: Buggeskov, Katrine B, et al.
Publicado: (2016)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)

Aclidinium inhibits human lung fibroblast to myofibroblast transition
por: Milara, Javier, et al.
Publicado: (2011)

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
por: Yorke, J, et al.
Publicado: (2010)

Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema
por: Mimae, Takahiro, et al.
Publicado: (2014)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society
por: McNulty, William, et al.
Publicado: (2014)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
por: Leidy, N K, et al.
Publicado: (2014)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
por: Buhl, Roland, et al.
Publicado: (2015)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Comparison of oxygen uptake during cycle ergometry with and without functional electrical stimulation in patients with COPD: protocol for a randomised, single-blind, placebo-controlled, cross-over trial
por: Medrinal, Clément, et al.
Publicado: (2016)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial)
por: Chatwin, M, et al.
Publicado: (2016)

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
por: Frith, Peter A, et al.
Publicado: (2015)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1ehidrcuhn8cqf66an75qqj05h